PMDA drug package insert
アロキシ静注0.75mg
PMDA Prescription drug · 大鵬薬品工業株式会社 · package insert May 27, 2021
Key facts
| Brand names | アロキシ静注0.75mg, アロキシ点滴静注バッグ0.75mg |
|---|---|
| Nonproprietary names | パロノセトロン塩酸塩 |
| Companies | 製造販売元／大鵬薬品工業株式会社, 提携先／HELSINN |
| Product type | Prescription drug |
| Therapeutic category | 5-HT3受容体拮抗型制吐剤 |
| Therapeutic category codes | 872391 |
| YJ codes | 2391404A1020, 2391404G1022 |
| Approval numbers | 22200AMX00247000, 22400AMX01368000 |
| Package insert edition | 第2版、用法及び用量変更 |
| Package insert date | May 27, 2021 |
| PMDA document key | 400107_2391404A1020_1 |
| PMDA company code | 400107 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: